 |
December 28, 2010
Cancer is a complex disease which is caused by multiple genetic and epigenetic changes. In addition, cancer is a genetic moving target capable of mutating into resistant or more aggressive forms. ...
|
 |
December 28, 2010
Since 1996 Prof Patrick Johnston has led the development of the Belfast City Hospital Cancer Centre and has built up this centre to the point where it now carries out a substantial number of ...
|
 |
December 28, 2010
Claudia McVie talks about the history of Tenovus and the work that the organisation has done to aid the fight against cancer. The early work of Tennovus included funding research on drugs such as ...
|
 |
December 28, 2010
Dr Ian Lewis, research manger at Tenovus, talks about the 'Sing for Life' choir that will be opening the 2010 NCRI meeting. This choir, made up of cancer patients, survivors, ...
|
 |
December 21, 2010
Alojz Peterle - Member of the European Parliament for Slovenia discusses how the current European health and research policy environment creates opportunities for innovation and creativity in ...
|
 |
December 21, 2010
An expert on the European network of cancer research in children and adolescents speaks to ecancer reporter Peter Goodwin about paedeatric cancer care across Europe including the work of SIOPE ...
|
 |
December 21, 2010
Role of WHO in cancer prevention and control (National Cancer Plans). Speaking at the Oncopolicy Forum 26th October 2010, Brussels.
|
 |
December 21, 2010
European Cancer Patient Coalition President Tom Hudson talks to ecancer about the patient role in informing EU policy on cancer. Speaking at the Oncopolicy Forum, 26th October 2010, Brussels.
|
 |
December 21, 2010
Dr Marija Seljak, Director of the Slovenian National Institute Of Public Health, talks to ecancer reporter Peter Goodwin at the Oncopolicy Forum, European Economic and Social Committee (EESC) ...
|
 |
December 21, 2010
Prof Alexander Eggermont , President of the European Academy of Cancer Sciences and Prof Anton Burns, Fellow of the European Academy of Cancer Sciences discuss the organisation’s role: Uniqueness ...
|
 |
December 21, 2010
Dr Andrzej Ryś discusses EU Commission commitment to the fight against cancer and the role of the European level in non-communicable chronic diseases. Speaking at the Oncopolicy Forum 26th October ...
|
 |
December 21, 2010
Ingrid Kössler of the European Economic and Social Committee, talks about the organisation’s role in tackling European health and cancer inequalities. Speaking at the Oncopolicy Forum 26th ...
|
 |
December 07, 2010
Dr Douglas Levine talks about the Cancer Genome Atlas, a collaborative project between the National Cancer Institute and the National Human Genome Research Institute. This project was designed to ...
|
 |
December 07, 2010
Prof Nicoletta Colombo speaks to ecancer.tv about trabectedin, a drug that has recently been approved for use with pegylated liposomal doxorubicin to treat partially platinum sensitive recurrent ...
|
 |
December 07, 2010
Dr Murat Gultekin and Dr Boris Vranes the president elect and current president of the European Network of Young Gynae Oncologists (ENYGO) speak to ecancer.tv about this society for young ...
|
 |
December 07, 2010
Dr Lucas Minig discusses a pilot study investigating the use of an inter-uterine devise (IUD) to treat young women with atypical endometrial hyperplasia (AEH) or early endometrial cancer limited ...
|
 |
December 07, 2010
Professor Christian Marth discusses whether clinicians should continue to follow-up ovarian cancer patients using the CA-125 tumour marker. A recent study has shown that early treatment in ...
|
 |
December 03, 2010
In this second part of the questions from members of the audience at the EHA patient advocacy session on 'access to clinical trials', the panel consider the need for independent ...
|
 |
December 03, 2010
Jana Pelouchová director of the Czech CML patient group "Diagnoza CML" discusses some of the barriers to patient participation in clinical trials and offers the patients perspective on these ...
|
 |
December 03, 2010
Clinical trials are a key step in the process of developing and improving treatment - and finding cures - for cancer. Patients with resistant or recurrent disease often seek out these trials as a ...
|
|
|
|
|
|
Featured
Content
Featuring websites that enhance the internet user’s experience.
|